Transarterial chemoembolization (TACE), a minimally invasive procedure for liver cancer, is an effective treatment strategy for patients with large, asymptomatic, or multifocal hepatocellular ...

SAN FRANCISCO -- An immuno-oncology (IO) regimen for intermediate-stage hepatocellular carcinoma (HCC) significantly extended treatment benefit versus transarterial chemoembolization (TACE), according ...

Please provide your email address to receive an email when new articles are posted on . Hepatocellular carcinoma, the sixth most common cancer, accounts for 90% of primary liver cancers worldwide. Its ...

Randomized phase II trial of TACE plus everolimus as first-line therapy in localized unresectable hepatocellular carcinoma (HCC): The TRACER trial. Background: TACE is regarded as the standard of care ...

Prayagraj: Kamala Nehru Memorial Hospital (KNMH) successfully performed its first-ever Trans-Arterial Chemoembolization (TACE) procedure on a two-year-old girl suffering from hepatoblastoma, a rare ...

Please provide your email address to receive an email when new articles are posted on . Postprocedural imaging showed 10% of patients had new portal vein thrombosis after transarterial ...

There's a possible new standard of care on the horizon for unresectable hepatocellular carcinoma (HCC) after years of failed attempts to improve upon the outcomes of the current protocol — stand-alone ...

GOTHENBURG, Sweden--(BUSINESS WIRE)--Mentice, the world’s leading endovascular simulation solution provider, has announced the release of a new simulation training software for transarterial ...